Specialty chemicals major Jubilant Ingrevia Ltd reported a 32.4% year-on-year decline in net profit for Q3 at ₹47 crore, compared with ₹69.4 crore in the same period last year. According to reports from CNBC TV18, revenue remained largely flat, rising 0.5% to ₹1,051 crore from ₹1,056.7 crore in Q3FY25. The company's EBITDA fell 8.5% to ₹126.1 crore from ₹137.9 crore a year ago, with EBITDA margin contracting to 12% from 13% in the corresponding quarter of the previous year. The challenging quarter was marked by significant drop in profitability despite revenue remaining largely stagnant.
The board of Jubilant Ingrevia has declared an interim dividend of ₹2.50 per equity share of Re. 1 each on the paid-up equity share capital of the company for the financial year 2025-26. As reported by CNBC TV18, the record date has been fixed as Tuesday, February 10, 2026, to determine the eligibility of shareholders for the interim dividend. The interim dividend will be paid or dispatched on or before March 4, 2026. Despite the weaker financial performance, this move aims to reward shareholders amidst the current earnings pressure.
In governance-related news, the board approved the re-appointment of Ameeta Chatterjee for a fresh five-year term, commencing April 17, 2026, and concluding on April 16, 2031, subject to shareholder approval. Chatterjee brings over 23 years of corporate experience in project finance and corporate finance to the company. This appointment strengthens the board's expertise in key financial areas during the current challenging period.
Shares of Jubilant Ingrevia Ltd ended at ₹655.45, down by ₹10.90, or 1.64% on the BSE on Wednesday, February 4, 2026. According to CNBC TV18, this decline occurred following the announcement of the company's Q3 financial results and dividend declaration. The market reaction reflects investor concerns over the significant profit decline despite relatively stable revenue performance.
